Chief Executive Officer & Chairperson of the Board
I joined SmartHealth Dx in November 2022 as our Chief Executive Officer. With my rich strategic-minded background as a corporate finance innovator and investment industry leader, I have orchestrated mission-critical financial strategies to enhance corporate value and strengthen operating performance for public and private companies in the life sciences industry. Read More
From 2017 to 2022, I led Oncocyte as their Chief Financial Officer of Oncocyte, a molecular diagnostic company, where I oversaw corporate growth from eight to more than 120 employees; conducted ten capital raises, bringing the company to fully-funded status; built the shareholder base from one institutional investor to more than fifty; negotiated and integrated three acquisitions; and secured the most significant licensing deal in company history with one of the largest and fastest-growing diagnostic laboratories in China.
From 2000 to 2017, Mr. Levine was Founder and Managing Member of Enable Capital Management, LLC, whose underlying investment vehicle, Enable Growth Partners, LP, was one of the largest funds providing growth capital to small and mid-sized public and private companies.
Before Enable Capital Management, Mr. Levine was a Founding Member of The Shemano Group, a San Francisco-based investment bank focused on the capital needs of technology and life science companies where Mr. Levine was widely recognized for originating and developing one of the largest alternative financing markets in the US, generating more than $100 billion of financings annually.
President & Chief Business Officer, Director
I currently hold the positions of President, Chief Business Officer, and Director here at SmartHealth Diagnostics. A technology executive with over 25 years of business experience bringing new products and concepts to commercial markets. I have expertise in biomarker discovery and development and have been published as an innovator in a scientific journal. Additionally, I was co-founder of Liquid Biosciences, which is focused on advanced AI and bioinformatics. I am highly proficient in mechanical engineering. Read More
Built a commercial partnership with the University of Pennsylvania’s School of Translational Medicine and have developed among the world’s first multi-omic biomarker discovery laboratories. This work was published in scientific journals and is widely recognized for its innovations. I have made novel discoveries in oncology, autoimmune disease, drug response companion diagnostics, and kidney and liver disease. This work has led to our current development partnership with Mayo Clinic.
A named inventor in several technologies and was granted US Patents in areas of Drug response to the TNF Class of drugs, the second largest in the world.I have served on Public and Private company Boards, in numerous C-suite roles, and as a Founder.
Chief Commercial Officer & Director
Chief Commercial Officer & Director I currently hold the position of CCO and Director of SmartHealth Dx, overseeing the commercialization and distribution of the diagnostic and imaging platforms. As a Senior healthcare executive and a 40-year veteran of the diagnostics imaging field with proven expertise, I have experience in engineering, service, manufacturing, marketing, sales, and business operations for several Fortune 500 companies including: Read More
• GE Healthcare, member of engineering teams to develop CT, MRI, Nuclear Medicine, and Ultrasound products allowing my advancement into management positions
• Philips Medical Systems, responsible for the $4B dollar imaging product portfolio, marketing, Commercialization, Sales, Service, Applications, and dealer networks
• Toshiba America Medical Systems/Canon Medical Systems, SVP and General Manager for the $3B medical imaging business, including operations, engineering, product portfolio development, finance, marketing, HR, sales, and service
• Esaote, President of the imaging division responsible for operations, finance, marketing, sales, and dealer network of the ultrasound and MR Product portfolio
I also held key industry position board seats on both the Radiological Society of North America (RSNA) and Medical Imaging & Technology Alliance (MITA), a division of the National Electrical Manufacturers Association (NEMA).
Susie Lu brings years of experience to her role as Chief Operating Officer and as President of Laboratory Services. She has a proven record of running large scale, highly complex laboratory operations by providing visionary and operational direction for the development and implementation of laboratory outreach programs in institutions. Read More
Some of Ms. Lu’s successes include, Columbia HCA Hospitals where she was an Executive Director; UCSF Health/Mount Zion Hospital, Stanford Health System/Lucile Packard Children’s Hospital, UCLA Health System/Santa Monica Hospital, where she served as Vice President of Operations; and Zhe Jiang University Medical Center in China, as the Chief Consultant (since 2014).
Over fifteen years of experience leading and transforming organizations with disruptive diagnostic technologies to revenue-stage companies with market-leading tests. Six capital raises including three underwritten deals. Read More
Launched multiple diagnostics globally, as kits and CLIA services, driving test inclusion as standard-of-care. Expertise in oncology and transplant monitoring markets. Track record of securing favorable Medicare and Commercial payor coverage and payment. Drive execution excellence across R&D, Medical Affairs, Operations, and Commercial to deliver high-quality products and services that provide customer satisfaction and repeat business.
Areas of expertise: Diagnostics, Oncology, Strategy, Fundraising, Commercialization, Organization building, Reimbursement, KOL development.
Gus Blass III
Gus J. Blass III is an investment management professional with over 40 years of experience. Mr. Blass has served on the boards of directors for public, non-public, and non-profit organizations and is qualified as an “audit committee financial expert” under Securities and Exchange Commission regulations.
Yonghong Wu is a Founder of Hangzhou Huili Medical Technology Development Co. LTD, one of the largest distributors of medical instruments and supplies in China, working with Roche, Johnson & Johnson, Abbott Diagnostics & Thermo Fisher. She has over 30 years of experience in the Chinese healthcare industry. Read More
As one of the top three in vitro diagnostic reagent service providers in Zhejiang Province, she has been awarded the Outstanding Economic Contribution Award for eight consecutive years.
Guy Pinkman is Chairman of the City of Lincoln Police and Fire Pension Plan Investment Board in Lincoln, Nebraska. In addition, he was a Captain/Paramedic with the Lincoln Fire and Rescue Department for over 30 years. He is a two-time Presidential appointee to the Pension Benefit Guaranty Corporation (PBGC) Advisory board. Read More
The PBGC board advises The Secretary of Commerce, Labor, and Treasury on policy, procedure, and investments covering over 34 million Americans with approximately $220B under management. A graduate of the University of Nebraska-Lincoln. He has completed studies in finance and economics worldwide, including China’s monetary system. Pension systems, institutions family offices, and consultants worldwide recognize Guy as a subject matter expert and a worldwide speaker on these issues.